Skip to main content
SpringerLink
Log in

Molecular Diagnosis of Micrometastasis in the Sentinel Lymph Node

  • Chapter
Selective Sentinel Lymphadenectomy for Human Solid Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 127))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Yoshino I, Nakanishi R, Osaki T, Takenoyama M, Taga S, Hanagiri T, et al. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. Chest 1999; 116:144–9.

    PubMed  CAS  Google Scholar 

  2. Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK. Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 1999;17:2334–40.

    PubMed  CAS  Google Scholar 

  3. Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton CE Jr, et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 1989;142:332–6.

    PubMed  CAS  Google Scholar 

  4. Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 1991;214:491–9.

    PubMed  CAS  Google Scholar 

  5. Cohen AM, Tremiterra S, Candela F, Thaler HT, Sigurdson ER. Prognosis of node-positive colon cancer. Cancer 1991;67:1859–61.

    PubMed  CAS  Google Scholar 

  6. Paik S, Bryant J, Park C, Fisher B, Tan-Chiu E, Hyams D, et al. erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. J Natl Cancer Inst 1998;90:1361–70.

    PubMed  CAS  Google Scholar 

  7. Fisher B, Redmond C, Wickerham DL, Bowman D, Schipper H, Wolmark N, et al. Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience. J Clin Oncol 1989;7:572–82.

    PubMed  CAS  Google Scholar 

  8. Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deshler A, et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Just 2001;93:979–89.

    CAS  Google Scholar 

  9. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392–9.

    PubMed  CAS  Google Scholar 

  10. Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993; 11:1751–6.

    PubMed  CAS  Google Scholar 

  11. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999;230:453–63.

    PubMed  CAS  Google Scholar 

  12. McMasters KM, Reintgen DS, Ross MI, Gershenwald JE, Edwards MJ, Sober A. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 2001;19:2851–5.

    PubMed  CAS  Google Scholar 

  13. Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654–8.

    PubMed  CAS  Google Scholar 

  14. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–8.

    PubMed  CAS  Google Scholar 

  15. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med 1998;339:941–6.

    PubMed  CAS  Google Scholar 

  16. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368–73.

    PubMed  CAS  Google Scholar 

  17. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J din Oncol 2000;18:2553–9.

    CAS  Google Scholar 

  18. Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK, et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 2000;7:120–4.

    PubMed  CAS  Google Scholar 

  19. Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 2001; 19:1128–36.

    PubMed  CAS  Google Scholar 

  20. Pelizzo MR, Boschin IM, Toniato A, Bernante P, Piotto A, Rinaldo A, et al. The sentinel node procedure with Patent Blue V dye in the surgical treatment of papillary thyroid carcinoma. Acta Otolaryngol 2001; 121:421–4.

    PubMed  CAS  Google Scholar 

  21. Hiratsuka M, Miyashiro I, Ishikawa O, Furukawa H, Motomura K, Ohigashi H, et al. Application of sentinel node biopsy to gastric cancer surgery. Surgery 2001;129:335–40.

    PubMed  CAS  Google Scholar 

  22. Akduman B, Fleshner NE, Ehrlich L, Klotz L. Early experience in intermediate-risk penile cancer with sentinel node identification using the gamma probe. Urology 2001;58:65–8.

    PubMed  CAS  Google Scholar 

  23. Van Trappen PO, Gyselman VG, Lowe DG, Ryan A, Oram DH, Bosze P, et al. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 2001;357:15–20.

    PubMed  Google Scholar 

  24. De Cicco C, Sideri M, Bartolomei M, Grana C, Cremonesi M, Fiorenza M, et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000;82:295–9.

    PubMed  Google Scholar 

  25. Liptay MJ, Masters GA, Winchester DJ, Edelman BL, Garrido BJ, Hirschtritt TR, et al. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg 2000;70:384–9.

    PubMed  CAS  Google Scholar 

  26. Tsioulias GJ, Wood TF, Morton DL, Bilchik AJ. Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms. Arch Surg 2000;135:926–32.

    PubMed  CAS  Google Scholar 

  27. Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998;133:288–92.

    PubMed  CAS  Google Scholar 

  28. Kitagawa Y, Fujii H, Mukai M, Kubota T, Ando N, Watanabe M, et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 2000;80:1799–1809.

    PubMed  CAS  Google Scholar 

  29. Miliotes G, Albertini J, Berman C, Heller R, Messina J, Glass F, et al. The tumor biology of melanoma nodal metastases. Am Surg 1996;62:81–8.

    PubMed  CAS  Google Scholar 

  30. Duff M, Hill AD, McGreal G, Walsh S, McDermott EW, O’Higgins NJ. Prospective evaluation of the morbidity of axillary clearance for breast cancer. Br J Surg 2001;88:114–7.

    PubMed  CAS  Google Scholar 

  31. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000;88:608–14.

    PubMed  CAS  Google Scholar 

  32. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345–50.

    PubMed  CAS  Google Scholar 

  33. d’Amore ES, Wick MR, Geisinger KR, Frizzera G. Primary malignant lymphoma arising in postmastectomy lymphedema. Another facet of the Stewart-Treves syndrome. Am J Surg Pathol 1990;14:456–63.

    PubMed  Google Scholar 

  34. Beitsch P, Balch C. Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection. Am J Surg 1992;164:462–5.

    PubMed  CAS  Google Scholar 

  35. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394–9.

    PubMed  CAS  Google Scholar 

  36. Cochran AJ, Essner R, Rose DM, Glass EC. Principles of sentinel lymph node identification: background and clinical implications. Langenbecks Arch Surg 2000;385:252–60.

    PubMed  CAS  Google Scholar 

  37. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818–22.

    PubMed  CAS  Google Scholar 

  38. Cochran AJ, Balda BR, Starz H, Bachter D, Krag DN, Cruse CW, et al. The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 2000;89:236–41.

    PubMed  CAS  Google Scholar 

  39. Hitchcock CL, Sampsel J, Young DC, Martin EW Jr, Arnold MW. Limitations with light microscopy in the detection of colorectal cancer cells. Dis Colon Rectum 1999;42:1046–52.

    PubMed  CAS  Google Scholar 

  40. Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 1999;354:896–900.

    PubMed  CAS  Google Scholar 

  41. Czerniecki BJ, Scheff AM, Callans LS, Spitz FR, Bedrosian I, Conant EF, et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999;85:1098–103.

    PubMed  CAS  Google Scholar 

  42. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 1999;91:1113–24.

    PubMed  CAS  Google Scholar 

  43. Kamath VJ, Giuliano R, Dauway EL, Cantor A, Berman C, Ku NN, et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 2001;136:688–92.

    PubMed  CAS  Google Scholar 

  44. Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol 1999;6:756–61.

    PubMed  CAS  Google Scholar 

  45. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271–6.

    PubMed  CAS  Google Scholar 

  46. Chen ZL, Wen DR, Coulson WF, Giuliano AE, Cochran AJ. Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology. Dis Markers 1991;9:239–48.

    PubMed  CAS  Google Scholar 

  47. Schreiber RH, Pendas S, Ku NN, Reintgen DS, Shons AR, Berman C, et al. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol 1999;6:95–101.

    PubMed  CAS  Google Scholar 

  48. Hammond ME, Fitzgibbons PL, Compton CC, Grignon DJ, Page DL, Fielding LP, et al. College of American Pathologists Conference XXXV: solid tumor prognostic factors—which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants. Arch Pathol Lab Med 2000;124:958–65.

    PubMed  CAS  Google Scholar 

  49. Bosman FT, de Goeij AF, Rousch M. Quality control in immunocytochemistry: experiences with the oestrogen receptor assay. J Clin Pathol 1992;45:120–4.

    PubMed  CAS  Google Scholar 

  50. Bertheau P, Cazals-Hatem D, Meignin V, de Roquancourt A, Verola O, Lesourd A, Sene C, Brocheriou C, Janin A. Variability of immunohistochemical reactivity on stored paraffin slides. J Clin Pathol 1998;51:310–4.

    Google Scholar 

  51. Rhodes A, Jasani B, Barnes DM, Bobrow LG, Miller KD. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol 2000;53:125–30.

    PubMed  CAS  Google Scholar 

  52. Layfield LJ, Gupta D, Mooney EE. Assessment of tissue estrogen and progesterone receptor levels: a survey of current practice, techniques, and quantitation methods. Breast J 2000;6:189–96.

    PubMed  CAS  Google Scholar 

  53. Kohlberger P, Gantert M, Volk-Orlowska T, Kieback DG, Gitsch G. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients. Anticancer Res 2001;21:697–9.

    PubMed  CAS  Google Scholar 

  54. Xu X, Roberts SA, Pasha TL, Zhang PJ. Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med 2000;124:1310–3.

    PubMed  CAS  Google Scholar 

  55. Cochran AJ, Wen DR, Herschman HR. Occult melanoma in lymph nodes detected by antiserum to S-100 protein. Int J Cancer 1984;34:159–63.

    PubMed  CAS  Google Scholar 

  56. Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol 1988;12:612–8.

    PubMed  CAS  Google Scholar 

  57. Carson KF, Wen DR, Li PX, Lana AM, Bailly C, Morton DL, et al. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996;20:834–40.

    PubMed  CAS  Google Scholar 

  58. Yu LL, Flotte TJ, Tanabe KK, Gadd MA, Cosimi AB, Sober AJ, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999;86:617–27.

    PubMed  CAS  Google Scholar 

  59. King R, Weibaecher KN, McGill G, Cooley E, Mihm M, Fisher DE. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol 1999;155:731–738.

    PubMed  CAS  Google Scholar 

  60. Shivers SC, Li W, Lin J, Stall A, Stafford M, Messina J, et al. The clinical relevance of molecular staging for melanoma. Recent Results Cancer Res 2001;158:187–99.

    PubMed  CAS  Google Scholar 

  61. Bostick PJ, Morton DL, Turner RR, Huynh KT, Wang HJ, Elashoff R, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 1999; 17:3238–44.

    PubMed  CAS  Google Scholar 

  62. Blaheta HJ, Schittek B, Breuninger H, Maczey E, Kroeber S, Sotlar K, et al. Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry. Int J Cancer 1998;79:318–23.

    PubMed  CAS  Google Scholar 

  63. Berois N, Varangot M, Osinaga E, Babino A, Caignault L, Muse I, et al. Detection of rare human breast cancer cells. Comparison of an immunomagnetic separation method with immunocytochemistry and RT-PCR. Anticancer Res 1997;17:2639–46.

    PubMed  CAS  Google Scholar 

  64. Van der Velde-Zimmermann D, Roijers JF, Bouwens-Rombouts A, De Weger RA, De Graaf PW, Tilanus MG, et al. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am J Pathol 1996;149:759–64.

    PubMed  Google Scholar 

  65. Hoon DS, Sarantou T, Doi F, Chi DD, Kuo C, Conrad AJ, et al. Detection of metastatic breast cancer by beta-hCG polymerase chain reaction. Int J Cancer 1996;69:369–74.

    PubMed  CAS  Google Scholar 

  66. Hoon DS, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D, et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995;13:2109–16.

    PubMed  CAS  Google Scholar 

  67. Kuo CT, Bostick PJ, Irie RF, Morton DL, Conrad AJ, Hoon DS. Assessment of messenger RNA of beta 1➡ 4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma. Clin Cancer Res 1998;4:411–8.

    PubMed  CAS  Google Scholar 

  68. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. JClin Oncol 1998;16:2632–40.

    CAS  Google Scholar 

  69. Morita R, Fujimoto A, Hatta N, Takehara K, Takata M. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression. J Invest Dermatol 1998;111:919–24.

    PubMed  CAS  Google Scholar 

  70. Frost P, Fidler IJ. Biology of metastasis. Cancer 1986;58:550–3.

    PubMed  CAS  Google Scholar 

  71. Price JE, Aukerman SL, Fidler IJ. Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. Cancer Res 1986;46:5172–8.

    PubMed  CAS  Google Scholar 

  72. Kitadai Y, Ellis LM, Takahashi Y, Bucana CD, Anzai H, Tahara E, et al. Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. Clin Cancer Res 1995;1:1095–1102.

    PubMed  CAS  Google Scholar 

  73. Blaheta HJ, Schittek B, Breuninger H, Garbe C. Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma. Recent Results Cancer Res 2001;158:137–46.

    PubMed  CAS  Google Scholar 

  74. Blaheta HJ, Ellwanger U, Schittek B, Sotlar K, MacZey E, Breuninger H, et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 2000;114:637–42.

    PubMed  CAS  Google Scholar 

  75. Goydos JS, Ravikumar TS, Germino FJ, Yudd A, Bancila E. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction. J Am Coll Surg 1998;187:182–8.

    PubMed  CAS  Google Scholar 

  76. Bilchik A, Miyashiro M, Kelley M, Kuo C, Fujiwara Y, Nakamori S, et al. Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay. Cancer 2000;88:1037–44.

    PubMed  CAS  Google Scholar 

  77. Bostick PJ, Huynh KT, Sarantou T, Turner RR, Qi K, Giuliano AE, et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer 1998;79:645–51.

    PubMed  CAS  Google Scholar 

  78. Miyashiro I, Kuo C, Huynh K, Iida A, Morton D, Bilchik A, et al. Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes. Clin Chem 2001;47:505–12.

    PubMed  CAS  Google Scholar 

  79. Taback B, Morton DL, O’Day SJ, Nguyen DH, Nakayama T, Hoon DS. The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma. Recent Results Cancer Res 2001;158:78–92.

    PubMed  CAS  Google Scholar 

  80. Hoon DS, Bostick P, Kuo C, Okamoto T, Wang HJ, Elashoff R, et al. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res 2000;60:2253–7.

    PubMed  CAS  Google Scholar 

  81. Sarantou T, Chi DD, Garrison DA, Conrad AJ, Schmid P, Morton DL, et al. Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res 1997;57:1371–6.

    PubMed  CAS  Google Scholar 

  82. Hamakawa H, Takemura K, Sumida T, Kayahara H, Tanioka H, Sogawa K. Histological study on pN upgrading of oral cancer. Virchows Arch 2000;437:116–21.

    PubMed  CAS  Google Scholar 

  83. Torrenga H, Rahusen FD, Meijer S, Borgstein PJ, van Diest PJ. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2001;54:550–2.

    PubMed  CAS  Google Scholar 

  84. O’Connell CD, Juhasz A, Kuo C, Reeder DJ, Hoon DS. Detection of tyrosinase mRNA in melanoma by reverse transcription-PCR and electrochemiluminescence. Clin Chem 1998;44:1161–9.

    PubMed  Google Scholar 

  85. Miyake Y, Fujiwara Y, Ohue M, Yamamoto H, Sugita Y, Tomita N, et al. Quantification of micrometastases in lymph nodes of colorectal cancer using real-time fluorescence polymerase chain reaction. Int J Oncol 2000;16:289–93.

    PubMed  CAS  Google Scholar 

  86. Mitas M, Mikhitarian K, Walters C, Baron PL, Elliott BM, Brothers TE, et al. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 2001;93:162–71.

    PubMed  CAS  Google Scholar 

  87. Blaheta HJ, Schittek B, Breuninger H, Sotlar K, Ellwanger U, Thelen MH, et al. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Am J Surg Pathol 1999;23:822–8.

    PubMed  CAS  Google Scholar 

  88. Takeuchi H, Kuo C, Morton DL, Wang HJ, Hoon DS. Expression of differentiation melanoma-associated antigen gene is associated with favorable disease outcome in advanced-stage melanomas. Cancer Res 2003;15:441–8.

    Google Scholar 

  89. Yoshioka S, Fujiwara Y, Sugita Y, Okada Y, Yano M, Tamura S, et al. Realtime rapid reverse transcriptase-polymerase chain reaction for intraoperative diagnosis of lymph node micrometastasis: clinical application for cervical lymph node dissection in esophageal cancers. Surgery 2002;132:34–40.

    PubMed  Google Scholar 

  90. Raja S, El-Hefnawy T, Kelly LA, Chestney ML, Luketich JD, Godfrey TE. Temperature-controlled primer limit for multiplexing of rapid, quantitative reverse transcription-PCR assays: application to intraoperative cancer diagnostics. Clin Chem 2002;48:1329–37.

    PubMed  CAS  Google Scholar 

  91. Kuo CT, Hoon DS, Takeuchi H, Turner R, Wang HJ, Morton DL, et al. Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. J Clin Oncol 2003:21;3566–72.

    PubMed  Google Scholar 

  92. Morton DL, Hoon DS, Cochran AJ, Turner RR, Essner R, Takeuchi H, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003;238:538–49.

    PubMed  Google Scholar 

  93. Sanchez-Cespedes M, Esteller M, Hibi K, Cope FO, Westra WH, Piantadosi S, et al. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence. Clin Cancer Res 1999;5:2450–4.

    PubMed  CAS  Google Scholar 

  94. Taback B, Nakayama T, Wiese D, Turner R, Bilchik A, Saha S, et al. Detection of colorectal micrometastasis in sentinel lymph nodes using the novel approach of PCR PNA clamping. Proc Am Assoc Cancer Res 2001;42:612.

    Google Scholar 

  95. Taback B. Bilchik AJ, Saha S, Nakayama T, Wiese DA, Turner RR, et al. Peptide nucleic acid clamp PCR: A novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes. Int J Cancer 2004, in press.

    Google Scholar 

  96. Shinozaki M, Fujimoto A, Morton DL, Hoon DS. Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanoma. Clin Cancer Res 2004;10:1753–7.

    PubMed  CAS  Google Scholar 

  97. Shinozaki M, O’Day S, Kuo C, Hoon DS. Detection and clinical utility of BRAF mutation in serum of melanoma patients. Clin Chem, Abstract for CNAPS III, pp9 (on line).

    Google Scholar 

  98. Dong G, Loukinova E, Chen Z, Gangi L, Chanturita TI, Liu ET, et al. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway. Cancer Res 2001;61:4797–808.

    PubMed  CAS  Google Scholar 

  99. Chen JJ, Peck K, Hong TM, Yang SC, Sher YP, Shih JY, et al. Global analysis of gene expression in invasion by a lung cancer model. Cancer Res 2001;61:5223–30.

    PubMed  CAS  Google Scholar 

  100. Zarrinkar PP, Mainquist JK, Zamora M, Stern D, Welsh JB, Sapinoso LM, et al. Arrays of arrays for high-throughput gene expression profiling. Genome Res 2001;11:1256–61.

    PubMed  CAS  Google Scholar 

  101. Kannan K, Kaminski N, Rechavi G, Jakob-Hirsch J, Amariglio N, Givol D. DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene 2001;20:3449–55.

    PubMed  CAS  Google Scholar 

  102. Dales JP, Plumas J, Palmerini F, Devilard E, Defrance T, Lajmanovich A, et al. Correlation between apoptosis microarray gene expression profiling and histopathological lymph node lesions. Mol Pathol 2001;54:17–23.

    PubMed  CAS  Google Scholar 

  103. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406:747–52.

    PubMed  CAS  Google Scholar 

  104. Li S, Ross DT, Kadin ME, Brown PO, Wasik MA. Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray. Am J Pathol 2001;158:1231–7.

    PubMed  CAS  Google Scholar 

  105. Macville MV, Van Der Laak JA, Speel EJ, Katzir N, Garini Y, Soenksen D, et al. Spectral imaging of multi-color chromogenic dyes in pathological specimens. Anal Cell Pathol 2001;22:133–42.

    PubMed  CAS  Google Scholar 

  106. Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart MJ, et al. Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am J Pathol 2000;157:1467–72.

    PubMed  CAS  Google Scholar 

  107. Ebina M, Martinez A, Birrer MJ, Ilona Linnoila R. In situ detection of unexpected patterns of mutant p53 gene expression in non-small cell lung cancers. Oncogene 2001;20:2579–86.

    PubMed  CAS  Google Scholar 

  108. Nasser IA, Lee AK, Bosari S, Saganich R, Heatley G, Silverman ML. Occult axillary lymph node metastases in “node-negative” breast carcinoma. Hum Pathol 1993;24:950–7.

    PubMed  CAS  Google Scholar 

  109. Carter BA, Jensen RA, Simpson JF, Page DL. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 2000;113:259–65.

    PubMed  CAS  Google Scholar 

  110. Siegel RJ. Surgical pathology of lymph nodes in cancer staging: routine and specialized techniques. Surg Oncol Clin North Am 1996;5:25–31.

    CAS  Google Scholar 

  111. Lilleng PK, Maehle BO, Hartveit F. The size of a micrometastasis in the axilla in breast cancer: a study of nodal tumour-load related to prognosis. Eur J Gynaecol Oncol 1998;19:220–4.

    PubMed  CAS  Google Scholar 

  112. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996;73:88–95.

    PubMed  CAS  Google Scholar 

  113. Sato F, Shimada Y, Li Z, Watanabe G, Maeda M, Imamura M. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg 2001;88:426–32.

    PubMed  CAS  Google Scholar 

  114. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999;86:482–6.

    PubMed  CAS  Google Scholar 

  115. Miyake Y, Yamamoto H, Fujiwara Y, Ohue M, Sugita Y, Tomita N, et al. Extensive micrometastases to lymph nodes as a marker for rapid recurrence of colorectal cancer: a study of lymphatic mapping. Clin Cancer Res 2001;7:1350–7.

    PubMed  CAS  Google Scholar 

  116. Braun S, Cevatli BS, Assemi C, Janni W, Kentenich CR, Schindlbeck C, et al. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol 2001;19:1468–75.

    PubMed  CAS  Google Scholar 

  117. Colpaert C, Vermeulen P, Jeuris W, Van Beest P, Goovaerts G, Weyler J, et al. Early distant relapse in “node-negative” breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol 2001;193:442–9.

    PubMed  CAS  Google Scholar 

  118. Komukai S, Nishimaki T, Watanabe H, Ajioka Y, Suzuki T, Hatakeyama K. Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes. Surgery 2000;127:40–6.

    PubMed  CAS  Google Scholar 

  119. Chen ZL, Perez S, Holmes EC, Wang HJ, Coulson WF, Wen DR, et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 1993;85:493–8.

    PubMed  CAS  Google Scholar 

  120. Izbicki JR, Passlick B, Hosch SB, Kubuschock B, Schneider C, Busch C, et al. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis. J Thorac Cardiovasc Surg 1996;112:623–30.

    PubMed  CAS  Google Scholar 

  121. Harrison LE, Choe JK, Goldstein M, Meridian A, Kim SH, Clarke K. Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. J Surg Oncol 2000;73:153–7.

    PubMed  CAS  Google Scholar 

  122. Mueller JD, Stein HJ, Oyang T, Natsugoe S, Feith M, Werner M, et al. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer 2000;89:1874–82.

    PubMed  CAS  Google Scholar 

  123. Nagakura S, Shirai Y, Yokoyama N, Hatakeyama K. Clinical significance of lymph node micrometastasis in gallbladder carcinoma. Surgery 2001;129:704–13.

    PubMed  CAS  Google Scholar 

  124. Hosch SB, Stoecklein NH, Pichlmeier U, Rehders A, Scheunemann P, Niendorf A, et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 2001; 19:1970–5.

    PubMed  CAS  Google Scholar 

  125. Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol 1988;12:612–18.

    Article  PubMed  CAS  Google Scholar 

  126. Gershenwald JE, Colome MI, Lee JE, Mansfield PF, Tseng C, Lee JJ, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253–60.

    PubMed  CAS  Google Scholar 

  127. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999;229:536–41.

    PubMed  CAS  Google Scholar 

  128. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565–68.

    Google Scholar 

  129. Dobashi K, Sugio K, Osaki T, Oka T, Yasumoto K. Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance. J Thorac Cardiovasc Surg 1997; 114:339–46.

    PubMed  CAS  Google Scholar 

  130. Clarke G, Ryan E, O’Keane JC, Crowe J, MacMathuna P. The detection of cytokeratins in lymph nodes of Duke’s B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol 2000;12:549–52.

    PubMed  CAS  Google Scholar 

  131. Tang R, Wang JY, Chen JS, Chang-Chien CR, Tang S, Lin SE, et al. Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum. J Am Coll Surg 1995;180:705–12.

    PubMed  CAS  Google Scholar 

  132. Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol 1999;17:19–24.

    PubMed  CAS  Google Scholar 

  133. Nakajo A, Natsugoe S, Ishigami S, Matsumoto M, Nakashima S, Hokita S, et al. Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer. Ann Surg Oncol 2001;8:158–62.

    PubMed  CAS  Google Scholar 

  134. Ribuffo D, Gradilone A, Vonella M, Chiummariello S, Cigna E, Haliassos N, et al. Prognostic significance of reverse transcriptase-polymerase chain reaction-negative sentinel nodes in malignant melanoma. Ann Surg Oncol 2003;10:396–402.

    PubMed  Google Scholar 

  135. Huang SK, Okamoto T, Morton DL, Hoon DS. Antibody responses to melanoma/melanocyte autoantigens in melanoma patients. J Invest Dermatol 1998;111:662–7.

    PubMed  CAS  Google Scholar 

  136. Hatta N, Takata M, Takehara K, Ohara K. Polymerase chain reaction and immunohistochemistry frequently detect occult melanoma cells in regional lymph nodes of melanoma patients. J Clin Pathol 1998;51:597–601.

    PubMed  CAS  Google Scholar 

  137. Wang X, Heller R, VanVoorhis N, Cruse CW, Glass F, Fenske N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994;220:768–74.

    PubMed  CAS  Google Scholar 

  138. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, et al. Molecular staging of malignant melanoma. JAMA 1998;280:1410–5.

    PubMed  CAS  Google Scholar 

  139. Goydos JS, Patel KN, Shih WJ, Lu SE, Yudd AP, Kempf JS, et al. Patterns of recurrence in patients with melanoma and histologically negative but RT-PCR-positive sentinel lymph nodes. J Am Coll Surg 2003;196:196–204.

    PubMed  Google Scholar 

  140. Palmieri G, Ascierto PA, Cossu A, Mozzillo N, Motti ML, Satriano SM, et al. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay. J Clin Oncol 2001;19:1437–43.

    PubMed  CAS  Google Scholar 

  141. Masuda N, Tamaki Y, Sakita I, Ooka M, Ohnishi T, Kadota M, et al. Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcription-polymerase chain reaction in breast cancer patients. Clin Cancer Res2000;6:4176–85.

    PubMed  CAS  Google Scholar 

  142. Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaoka S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 1994;74:1595–1600.

    PubMed  CAS  Google Scholar 

  143. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol 1996;148:649–56.

    PubMed  CAS  Google Scholar 

  144. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995;55:3417–20.

    PubMed  CAS  Google Scholar 

  145. Ooka M, Sakita I, Fujiwara Y, Tamaki Y, Yamamoto H, Aihara T, et al. Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients. Oncol Rep 2000;7:561–6.

    PubMed  CAS  Google Scholar 

  146. Kataoka A, Mori M, Sadanaga N, Ueo H, Tsuji K, Rai Y, et al. RT-PCR detection of breast cancer cells in sentinel lymph modes. Int J Oncol 2000;16:1147–52.

    PubMed  CAS  Google Scholar 

  147. Hoon DS, Sarantou T, Doi F, Chi DD, Kuo C, Conrad AJ, et al. Detection of metastatic breast cancer by beta-hCG polymerase chain reaction. Int J Cancer 1996;69:369–74.

    PubMed  CAS  Google Scholar 

  148. Lockett MA, Baron PL, O’Brien PH, Elliott BM, Robison JG, Maitre N, et al. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. J Am Coll Surg 1998;187:9–16.

    PubMed  CAS  Google Scholar 

  149. Yun K, Gunn J, Merrie AE, Phillips LV, McCall JL. Keratin 19 mRNA is detectable by RT-PCR in lymph nodes of patients without breast cancer. Br J Cancer 1997;76:1112–3.

    PubMed  CAS  Google Scholar 

  150. Merrie AE, Yun K, Gunn J, Phillips LV, McCall JL. Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer. Br J Cancer 1999;80:2019–24.

    PubMed  CAS  Google Scholar 

  151. Fujie T, Mori M, Ueo H, Sugimachi K, Akiyoshi T. Expression of MAGE and BAGE genes in Japanese breast cancers. Ann Oncol 1997;8:369–72.

    PubMed  CAS  Google Scholar 

  152. Wascher RA, Bostick PJ, Huynh KT, Turner R, Qi K, Giuliano AE, et al. Detection of MAHE-A3 in breast cancer patients’ sentinel lymph nodes. Br J Cancer 2001;85:1340–6.

    PubMed  CAS  Google Scholar 

  153. Aihara T, Fujiwara Y, Miyake Y, Okami J, Okada Y, Iwao K, et al. Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers. Cancer Lett 2000;150:79–84.

    PubMed  CAS  Google Scholar 

  154. Ichikawa Y, Ishikawa T, Momiyama N, Yamaguchi S, Masui H, Hasegawa S, et al. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin. Clin Exp Metastasis 1998;16:3–8.

    PubMed  CAS  Google Scholar 

  155. Weitz J, Kienle P, Magener A, Koch M, Schrodel A, Willeke F, et al. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 1999;5:1830–6.

    PubMed  CAS  Google Scholar 

  156. Bernini A, Spencer M, Frizelle S, Madoff RD, Willmott LD, McCormick SR, et al. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes. Cancer Detect Prev 2000;24:72–9.

    PubMed  CAS  Google Scholar 

  157. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223–8.

    PubMed  CAS  Google Scholar 

  158. Noura S, Yamamoto H, Ohnishi T, Masuda N, Matsumoto T, Takayama O, et al. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 2002;20:4232–41.

    PubMed  CAS  Google Scholar 

  159. Cortesina G, Martone T, Galeazzi E, Olivero M, De Stefani A, Bussi M, et al. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int J Cancer 2000;89:286–92.

    PubMed  CAS  Google Scholar 

  160. Salerno CT, Frizelle S, Niehans GA, Ho SB, Jakkula M, Kratzke RA, et al. Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction. Chest 1998;113:1526–32.

    PubMed  CAS  Google Scholar 

  161. Edelstein RA, Zietman AL, de las Morenas A, Krane RJ, Babayan RK, Dallow KC, et al. Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Urology 1996;47:370–5.

    PubMed  CAS  Google Scholar 

  162. Deguchi T, Doi T, Ehara H, Ito S, Takahashi Y, Nishino Y, et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1993;53:5350–4.

    PubMed  CAS  Google Scholar 

  163. Ferrari AC, Stone NN, Eyler JN, Gao M, Mandeli J, Unger P, et al. Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer. J Natl Cancer Inst 1997;89:1498–1504.

    PubMed  CAS  Google Scholar 

  164. Noguchi S, Hiratsuka M, Furukawa H, Aihara T, Kasugai T, Tamura S, et al. Detection of gastric cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res 1996;87:650–4.

    PubMed  CAS  Google Scholar 

  165. McDonald LA, Walker DM, Gibbins JR. Cervical lymph node involvement in head and neck cancer detectable as expression of a spliced transcript of type II keratin K5. Oral Oncol 1998;34:276–83.

    PubMed  CAS  Google Scholar 

  166. Kijima F, Natsugoe S, Takao S, Aridome K, Baba M, Yoshifumi M, et al. Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma. Oncology 2000;58:38–44.

    PubMed  CAS  Google Scholar 

  167. Kano M, Shimada Y, Kaganoi J, Sakurai T, Li Z, Sato F, et al. Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA. Br J Cancer 2000;82:429–35.

    PubMed  CAS  Google Scholar 

  168. Okami J, Dohno K, Sakon M, Iwao K, Yamada T, Yamamoto H, et al. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma. Clin Cancer Res 2000;6:2326–32.

    PubMed  CAS  Google Scholar 

  169. Taback B, Hashimoto K, Kuo CT, Chan A, Giuliano AE, Hoon DS. Molecular lymphatic mapping of the sentinel lymph node. Am J Pathol 2002;161:1153–61.

    PubMed  CAS  Google Scholar 

  170. Morton DL. Lymphatic mapping and sentinel lymphadenectomy for melanoma: past, present and future (2nd International Sentinel Node Congress, 1–4 December 2000, Santa Monica, CA). Ann Surg Oncol (in press).

    Google Scholar 

  171. Takeuchi H, Morton DL, Kuo C, Turner RR, Elashoff D, Elashoff R, et al. Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients. J Clin Oncol (submitted).

    Google Scholar 

  172. Manzotti M, Dell’Orto P, Maisonneuve P, Zurrida S, Mazzarol G, Viale G. Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int J Cancer 2001;95:307–12.

    PubMed  CAS  Google Scholar 

  173. Sakaguchi M, Virmani A, Dudak MW, Peters GN, Leitch AM, Saboorian H, Gazdar AF, Euhus DM. Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer. Ann Surg Oncol 2003;10:117–25.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Oncology, John Wayne Cancer Institute, Saint John’s Health Center, Santa Monica, California

    Hiroya Takeuchi, Robert A. Wascher, Christine Kuo & Dave S.B. Hoon

  2. Department of Pathology, John Wayne Cancer Institute, Saint John’s Health Center, Santa Monica, California

    Roderick R. Turner

Authors
  1. Hiroya Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert A. Wascher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christine Kuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roderick R. Turner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dave S.B. Hoon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgery, University of California, Medical Center at Mount Zion, 1600 Divisadero Street, San Francisco, CA, 94143

    Stanley P. L. Leong

  2. Department of Surgery, Keio University, School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan

    Yuko Kitagawa  & Masaki Kitajima  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Takeuchi, H., Wascher, R.A., Kuo, C., Turner, R.R., Hoon, D.S. (2005). Molecular Diagnosis of Micrometastasis in the Sentinel Lymph Node. In: Leong, S.P.L., Kitagawa, Y., Kitajima, M. (eds) Selective Sentinel Lymphadenectomy for Human Solid Cancer. Cancer Treatment and Research, vol 127. Springer, Boston, MA. https://doi.org/10.1007/0-387-23604-X_12

Download citation

  • DOI: https://doi.org/10.1007/0-387-23604-X_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-23603-2

  • Online ISBN: 978-0-387-23604-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation